News
Mike McCune, MD, PhD, head of the HIV Frontiers Program at the Gates Foundation, delivered an upbeat message at the ASGCT annual conference in New Orleans last week, showcasing the progress being made ...
The clinical trials are sponsored by IO Biotech and conducted in collaboration with Merck, which is supplying pembrolizumab. IO Biotech maintains global commercial rights to Cylembio. Cylembio ® is a ...
1d
Newspoint on MSNJEE Advanced 2025: IIT launches 2 new BTech programs, career will shine in AI and Biomedical Engineering fields..IIT Madras has announced two new BTech programs for the academic session 2025-26. These programs will be conducted in the ...
Industry Veteran to Support Acceleration of Key Pipeline Projects and Novel BiTAC Antibody Formats Towards Clinical Studies ...
The proposed sale is expected to close in the third quarter, subject to approval by the U.S. Bankruptcy Court for the Eastern ...
Regeneron Commits to Comply with Company's Privacy Policy and All Applicable Law; No Changes to 23andMe's Privacy Policy or Consumer Genome Services Transaction Subject to Court Approval SAN FRANCISCO ...
FBT ETF launched 19 years ago and has delivered exceptional returns compared to the broader Health Care sector. Read why FBT ...
PDS Biotechnology Corporation (NASDAQ: PDSB) Q1 2025 Earnings Call Transcript May 14, 2025 PDS Biotechnology Corporation ...
The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 ...
LBS Centre for Science and Technology; Palayam, Nandavanam, Thiruvananthapuram 695 033, has invited applications for the State Eligibility Test (SET), July ...
Sustainability is not enough: MA Regenerative Design goes further, helping you to develop your creative practice for a more-than-human world. From October 2024, you can only apply for a maximum of 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results